The state of California currently has 940 active clinical trials seeking participants for Cancer research studies. These trials are conducted in various cities, including Los Angeles, San Francisco, San Diego and Sacramento.
PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer
Recruiting
The standard of care imaging of prostate cancer metastases recommended by the National Comprehensive Cancer Network (NCCN), CT of the chest/abdomen/pelvis and bone scan, may be suboptimal. PyL is a novel PET tracer designed to detect prostate specific membrane antigen (PSMA) expressed on prostate cancer cells. PyL PET/CT may provide improved evaluation of clinically significant metastases in patients with prostate cancer.
Gender:
Male
Ages:
18 years and above
Trial Updated:
07/26/2021
Locations: Hoag Memorial Hospital Presbyterian, Irvine, California
Conditions: Prostate Cancer
A Multi-center Randomized Control Cross-over Study to Evaluate the Safety and Effectiveness of the Dayspring Active Wearable Compression Device vs. an Advanced Pneumatic Compression Device for Treating Breast Cancer Related Lymphedema
Recruiting
To evaluate the Dayspring Active Wearable Compression Device in contrast to an advanced pneumatic compression device (APCD)
Gender:
All
Ages:
18 years and above
Trial Updated:
05/28/2021
Locations: PT works, Los Altos, California +1 locations
Conditions: Lymphedema, Lymphedema of Upper Arm, Lymphedema, Breast Cancer
A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery
Recruiting
To evaluate the Dayspring Active Wearable Compression Technology in enhancing lymph movement and its safety and effectiveness after lymphatic surgery
Gender:
All
Ages:
18 years and above
Trial Updated:
05/18/2021
Locations: Dung Nguyen, MD, PharmD, Palo Alto, California
Conditions: Lymphedema, Lymphedema, Breast Cancer, Lymphedema Arm
Evaluation of the PhageTech Virus BioResistor
Recruiting
To evaluate the effectiveness of the PhageTech Virus BioResistor to detect bladder cancer biomarkers.
Gender:
All
Ages:
18 years and above
Trial Updated:
02/12/2021
Locations: Providence Saint John's Health Center and the Saint John's Cancer Institute, Santa Monica, California
Conditions: Bladder Cancer